Novo Nordisk is facing difficulties to replace the existing drug Saxenda (liraglutide) with a new drug Wegovy (semaglutide) in the obesity treatment market due to manufacturing issues.On Thursday, the Danish multinational drugmaker said in an IR meeting for second-quarter earnings that it would be d
The Lithuanian Biotechnology Association (LBTA) said on Friday that they signed a memorandum of understanding (MOU) with Korea Biotechnology Industry (Korea BIO) to establish stronger cooperation with Korean bio-companies in the field of high value-added technologies.In an interview with Korea Biome
Macrogen, a company specializing in precision medicine biotechnology, said on Monday that it is expanding its multiomics business by providing domestic and foreign protein analysis services.Multiomics is a high-level analytical technique that integrates genomic, transcriptome, and proteome data, and
KT, the second-largest telco in Korea, has been accelerating its entry into the digital healthcare sector recently. Now, the company is seeking to expand its influence to lead the local healthcare ecosystem.“The healthcare industry is expanding from diagnosis and treatment to prevention and manageme
The Ministry of Food and Drug Safety said that it has begun a preliminary review of Comirnaty, Pfizer’s Covid-19 vaccine developed to fight the Omicron variant.Pfizer Korea applied to the ministry on Friday for a preliminary review on clinical trial data of the Omicron-targeting Comirnaty vaccine.Th
Huinno, a digital healthcare firm, said Friday the Ministry of Food and Drug Safety (MFDS) chose the company to provide technical support for a national project to adopt the international standards on the quality control of the latest medical devices.The project is jointly organized by Seoul Nationa
Bukwang Pharmaceutical its subsidiary Dyna Therapeutics obtained a composition patent for SOL-804, a prostate cancer drug candidate, in Korea and Japan.With the additional two patent registrations, Dyna has completed the patent registration in 32 countries including the U.S., Australia, Mexico, and
Celltrion Healthcare said it has officially begun preparing to directly market its drugs in the U.S. by acquiring Celltrion USA from Celltrion.Celltrion Healthcare and Celltrion believe the acquisition will help maximize profits for both companies by strengthening each company's core competency and
HLB Life Science, which owns rights to market Jiangsu Hengrui Medicine’s anticancer drug pyrotinib in Korea, said it would expand new pipelines on the back of the recent success of a phase 3 pyrotinib trial.Jiangsu Hengrui announced that the phase 3 clinical trial of pyrotinib met the primary endpoi
Kyung Hee University Medical Center (KHMC) said it ranked 10th in the 2021 Inpatient Experience Evaluation conducted by the Health Insurance Review and Assessment Service (HIRA) on 359 general hospitals nationwide.According to the hospital, KHMC received a score of 88.6, ranking tenth among all gene
The Ministry of Health and Welfare recently changed the official English name of “Oriental medical doctor” to “doctor of Korean medicine,” causing a strong backlash from the medical community.Doctors said the new name could be misleading because English-speaking people could confuse Western medical
Professor Virginijus Siksnys of the Institute of Biotechnology at Vilinus University opened the third and final day of Bio-Interplex (BIX) Korea 2022 with the keynote speech on the past, present and future of CRISPR-Cas technology on Friday at COEX, southern Seoul.CRISPR technology gained widespread
SillaJen announced Thursday that it tapped Kim Jae-kyung, a former head of LabGenomics, as the new CEO.With Kim taking the helm, SillaJen said it would be able to normalize stock trading and strengthen corporate transparency.Kim was a founding member and CEO of LabGenomics. He also served as an adju
Ten hypertension generic drugs containing azelnidine in the calcium channel blocker (CCB) class, including Intro Bio Pharma’s Intro Azelnidipine, are eligible for reimbursement, the health insurance review agency said.The Health Insurance Review and Assessment Service (HIRA) released the results of
ATGC said Thursday that it signed a strategic partnership license and supply agreement with RELIFE, an Italian biopharma firm, for its botulinum toxin type A (ATGC-100) as part of its strategic entry into Europe.Under the agreement, ATGC will grant RELIFE exclusive rights to develop, register, promo
The quarantine authorities on Thursday lowered their forecast for the peak of daily Covid-19 cases to 150,000.“According to several mathematical analysis groups, the majority opinion is that the peak will come in August,” said Lee Sang-won, head of the epidemiological investigation and analysis team
On the opening day of Bioplus-Interphex (BIX) Korea 2022 on Wednesday, Korea Biomedical Review (KBR) spoke to a variety of foreign companies to discover their intentions for attending the event this year.At the forefront of discussions was healthcare digitalization.Merck gave an engaging presentatio
Bridge Biotherapeutics announced that it would release non-clinical data of idiopathic pulmonary fibrosis (IPF) treatment candidates BBT-301 and BBT-209 at the IPF summit 2022 to be held at Boston from Aug. 29 to Sept. 1.According to the company, BBT-301 is a novel drug candidate which fights the di
CGBio said it has signed a strategic partnership agreement with Orthofix Medical, a U.S.-based global medical device company, to license out its Novosis Putty, a bone substitute, and supply its finished products to the U.S. and Canada.According to the company, Novosis Putty is a next-generation reco
A joint research team of Korean and U.S. researchers said they found a new cause of senescence in mice.The research team of Professor Jeon Ok-hee at Korea University College of Medicine and Professor Irina Conboy at the University of California, Berkeley, published a paper, titled, “Systemic inducti